M06.35 Rheumatoid nodule, hip

Name of the Condition

• Rheumatoid nodule, hip

Summary

Rheumatoid nodule, hip is a localized extra-articular manifestation of rheumatoid arthritis (RA) involving firm, subcutaneous nodules in the hip region. These nodules are composed of inflammatory tissue and are associated with chronic, seropositive RA. They may occur in other conditions but are most strongly linked to RA. Diagnosis relies on clinical recognition and correlation with underlying joint disease.

Causes

Rheumatoid nodules form due to chronic inflammation and immune complex deposition in subcutaneous tissues. They are associated with severe, long-standing RA, particularly in patients with high rheumatoid factor or anti-CCP antibody levels. The exact pathogenesis involves dysregulated immune responses and fibroblast activation, leading to nodule formation. They may also develop at sites of trauma or injection.

Risk Factors

• Severe, long-standing rheumatoid arthritis (especially seropositive disease).
• High rheumatoid factor or anti-CCP antibody titers.
• Presence of other extra-articular RA manifestations (e.g., vasculitis).
• Chronic inflammation and immune dysregulation.
• Trauma or pressure to affected areas.

Symptoms

• Firm, movable subcutaneous nodules in the hip area.
• Nodules may be painless or tender.
• May be associated with underlying joint inflammation or deformity.

Diagnosis

Diagnosis is based on clinical examination and correlation with a history of rheumatoid arthritis. Imaging (e.g., ultrasound or MRI) may be used to confirm the presence of subcutaneous nodules and rule out other conditions. Biopsy is rarely needed but can confirm the diagnosis if uncertainty exists.

Treatment Options

Treatment focuses on managing underlying rheumatoid arthritis. Options include disease-modifying antirheumatic drugs (DMARDs), biologic agents, or corticosteroids to reduce inflammation. Nodules may persist despite treatment but often stabilize or regress with improved disease control. Surgical removal is rarely required unless nodules cause functional impairment or discomfort.

Prognosis and Follow-Up

Prognosis depends on the severity of underlying RA. Nodules may wax and wane with disease activity. Regular follow-up with a rheumatologist is recommended to monitor RA progression and adjust treatment as needed. Nodules themselves are generally benign but may indicate poorly controlled disease.

Complications

• Ulceration or infection of nodules, particularly if they rupture.
• Functional impairment if nodules affect mobility or pressure points.
• Psychosocial impact due to visible or symptomatic nodules.

Lifestyle & Prevention

• Optimize RA management to reduce inflammation and nodule formation.
• Avoid trauma or pressure to the hip area to prevent nodule development or irritation.
• Smoking cessation, as smoking is associated with increased nodule risk and severity.

When to Seek Professional Help

Seek medical attention if nodules become painful, ulcerated, or increase in size, or if there are signs of infection (e.g., redness, drainage). Prompt evaluation is also recommended if hip mobility or function is affected.

Tips for Medical Coders

Document the anatomical location (hip) and confirm association with rheumatoid arthritis. Ensure clinical correlation is noted, as nodules may occur in other conditions. Code M06.35 is specific to hip involvement; use additional codes for RA if applicable.